These drugs are insanely expensive and desired by a ton of patients, and the patient can never get off them, James Gelfand, the president and CEO of the employer advocacy group ERISA Industry Committee, told Insider over the summer
Some patients see LDL reduction of 1020%, which compounds the cardiovascular benefits of weight loss itself
I'll do a full blog on it once I've been on it for 4-6 weeks
If you've spent ten minutes staring at electrolyte products online trying to work out which one is actually right for you, here's the honest answer: most of them aren't designed with GLP-1 patients in mind
In total, 85%, 89%, and 91% of participants lost 5% bodyweight with 5, 10, and 15 mg of tirzepatide, respectively (vs
Patients with type 2 diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death